Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

635 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tirzepatide for Obesity Treatment and Diabetes Prevention.
Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, Wilding JPH, Perreault L, Zhang S, Battula R, Bunck MC, Ahmad NN, Jouravskaya I; SURMOUNT-1 Investigators. Jastreboff AM, et al. Among authors: le roux cw. N Engl J Med. 2024 Nov 13. doi: 10.1056/NEJMoa2410819. Online ahead of print. N Engl J Med. 2024. PMID: 39536238
Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and -2).
Wharton S, le Roux CW, Kosiborod MN, Platz E, Brueckmann M, Jastreboff AM, Ajaz Hussain S, Pedersen SD, Borowska L, Unseld A, Kloer IM, Kaplan LM; SYNCHRONIZE‐1 and ‐2 trial committees and investigators. Wharton S, et al. Among authors: le roux cw. Obesity (Silver Spring). 2024 Nov 4. doi: 10.1002/oby.24184. Online ahead of print. Obesity (Silver Spring). 2024. PMID: 39495965
Survodutide for the Treatment of Obesity: Rationale and Design of the SYNCHRONIZE Cardiovascular Outcomes Trial.
Kosiborod MN, Platz E, Wharton S, le Roux CW, Brueckmann M, Ajaz Hussain S, Unseld A, Startseva E, Kaplan LM; SYNCHRONIZE–CVOT Trial Committees and Investigators. Kosiborod MN, et al. Among authors: le roux cw. JACC Heart Fail. 2024 Oct 23:S2213-1779(24)00662-0. doi: 10.1016/j.jchf.2024.09.004. Online ahead of print. JACC Heart Fail. 2024. PMID: 39453356 Free article. Review.
Subclassification of obesity for precision prediction of cardiometabolic diseases.
Coral DE, Smit F, Farzaneh A, Gieswinkel A, Tajes JF, Sparsø T, Delfin C, Bauvain P, Wang K, Temprosa M, De Cock D, Blanch J, Fernández-Real JM, Ramos R, Ikram MK, Gomez MF, Kavousi M, Panova-Noeva M, Wild PS, van der Kallen C, Adriaens M, van Greevenbroek M, Arts I, Le Roux C, Ahmadizar F, Frayling TM, Giordano GN, Pearson ER, Franks PW. Coral DE, et al. Among authors: le roux c. Nat Med. 2024 Oct 24. doi: 10.1038/s41591-024-03299-7. Online ahead of print. Nat Med. 2024. PMID: 39448862
Prevalence of obesity in people with and without type 1 diabetes across Belgium, Kuwait, and Mexico: an IMI2 SOPHIA study.
Al Ozairi E, Steenackers N, Pazmino S, Alattar AT, Al Kandari J, Almeda-Valdes P, Antonio-Villa NE, Delfin C, Faradji RN, García-Tuomola A A, Irshad M, Longenecker JC, Rosen J, Hurtado Del Pozo C, Sparsø T, Lavens A, Mathieu C, Van der Schueren B, le Roux CW. Al Ozairi E, et al. Among authors: le roux cw. EClinicalMedicine. 2024 Oct 3;77:102869. doi: 10.1016/j.eclinm.2024.102869. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39416388 Free PMC article.
635 results